BVF PARTNERS L P/IL
18 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-14 | XOMA | XOMA Royalty Corp | U | 3,635,758 | — | — | filing |
| 2026-07-14 | XOMA | XOMA Royalty Corp | U | 2,773,545 | — | — | filing |
| 2026-07-14 | XOMA | XOMA Royalty Corp | U | 412,000 | — | — | filing |
| 2026-07-14 | XOMA | XOMA Royalty Corp | U | 772,000 | — | — | filing |
| 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | Sale | 837,914 | $106.50 | $89.2M | filing |
| 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | Sale | 627,597 | $106.50 | $66.8M | filing |
| 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | Sale | 113,289 | $106.50 | $12.1M | filing |
| 2026-06-26 | KYMR | Kymera Therapeutics, Inc. | Sale | 51,858 | $106.50 | $5.5M | filing |
| 2026-05-14 | XOMA | XOMA Royalty Corp | C | 2,313,000 | $4.03 | $9.3M | filing |
| 2026-05-14 | XOMA | XOMA Royalty Corp | C | 1,506,000 | $4.03 | $6.1M | filing |
| 2026-05-14 | XOMA | XOMA Royalty Corp | C | 772,000 | $4.03 | $3.1M | filing |
| 2026-05-14 | XOMA | XOMA Royalty Corp | C | 412,000 | $4.03 | $1.7M | filing |
| 2026-03-31 | MLTX | MoonLake Immunotherapeutics | Sale | 1,932,354 | $16.79 | $32.4M | filing |
| 2026-03-31 | MLTX | MoonLake Immunotherapeutics | Sale | 1,569,116 | $16.79 | $26.3M | filing |
| 2026-03-31 | MLTX | MoonLake Immunotherapeutics | Sale | 248,530 | $16.79 | $4.2M | filing |
| 2025-06-30 | KYMR | Kymera Therapeutics, Inc. | Buy | 142,604 | $44.00 | $6.3M | filing |
| 2025-06-30 | KYMR | Kymera Therapeutics, Inc. | Buy | 115,783 | $44.00 | $5.1M | filing |
| 2025-06-30 | KYMR | Kymera Therapeutics, Inc. | Buy | 58,780 | $44.00 | $2.6M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.